NexGen Launches Xcoil Large-Vessel, 18-mm Thrombectomy System
August 6, 2018—NexGen Medical Systems, Inc. announced the completion of the first human use of the company's Xcoil large vessel (18-mm) thrombectomy system for the treatment of deep vein thrombosis. The new device—which is an expansion of the Xcoil 12-mm system—is designed to rapidly remove blood clots in large vessels, such as the iliac vein.
According to the company, the Xcoil thrombectomy systems are composed of the Encapsulator sheath and the Retractor catheter. The Retractor is used to engage and extract the clot, pull it into the Encapsulator, and remove the clot from the body, while minimizing the need for lytic drugs.
In NexGen's announcement, David Buechner, MD, commented, “Our therapeutic goal is to rapidly restore blood flow by removing the clot, quickly and safely, while minimizing the need for clot-dissolving drugs which are not appropriate for all patients and can have negative side effects. The Xcoil thrombectomy system provides a rapid mechanical solution and may improve outcomes, and reduce costs, for our patients.”